MME and acute lymphoblastic leukemia: CD10 was found to be more frequently positive in B-ALL patients P < 0.0001 (OR, 32.500; 95% CI 12.462–84.755) and prognostic risk to be lower in B-ALL patients P < 0.0001 (OR, 0.016; 95% CI 0.002–0.122).